| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 194.50M | 193.00M | 196.62M | 249.30M | 371.90M |
| Gross Profit | 139.04M | 143.24M | 149.94M | 159.56M | 240.48M |
| EBITDA | 53.97M | 47.67M | 53.81M | 213.68M | 225.21M |
| Net Income | 11.67M | 1.21M | 45.97M | 142.61M | 99.74M |
Balance Sheet | |||||
| Total Assets | 235.57M | 231.79M | 206.89M | 251.47M | 599.30M |
| Cash, Cash Equivalents and Short-Term Investments | 97.14M | 87.13M | 87.51M | 120.17M | 282.30M |
| Total Debt | 47.40M | 54.86M | 30.67M | 45.51M | 126.86M |
| Total Liabilities | 59.83M | 67.76M | 44.37M | 63.27M | 151.35M |
| Stockholders Equity | 175.74M | 164.04M | 162.52M | 188.19M | 447.95M |
Cash Flow | |||||
| Free Cash Flow | 44.67M | 32.94M | 68.44M | 57.08M | 155.42M |
| Operating Cash Flow | 53.37M | 44.71M | 71.58M | 59.47M | 158.95M |
| Investing Cash Flow | -46.05M | -18.59M | -9.38M | 244.36M | 65.01M |
| Financing Cash Flow | -35.06M | -36.22M | -102.85M | -465.96M | -255.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$83.40M | -4.24 | 4.49% | ― | -1.14% | ― | |
62 Neutral | HK$2.38B | 10.65 | 10.57% | 9.18% | 3.78% | -21.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$157.57M | -61.60 | -5.53% | 10.75% | -23.76% | -9785.71% | |
54 Neutral | HK$266.00M | 8.11 | 4.46% | ― | -7.95% | 98.95% | |
49 Neutral | HK$158.00M | 0.57 | -11.64% | ― | -5.89% | 71.06% | |
43 Neutral | HK$229.30M | 3.33 | ― | ― | ― | ― |